| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 7.220 | - | - | - | - | - | - |
| Total Income - EUR | 0 | 0 | 0 | 7.220 | - | - | - | - | - | - |
| Total Expenses - EUR | 893 | 8.487 | 9.247 | 31.682 | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | -893 | -8.487 | -9.246 | -24.462 | - | - | - | - | - | - |
| Net Profit/Loss - EUR | -893 | -8.487 | -9.246 | -24.534 | - | - | - | - | - | - |
| Employees | 0 | 1 | 1 | 2 | - | - | - | - | - | - |
Check the financial reports for the company - Clc Pharmaceuticals S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.443 | - | - | - | - | - | - |
| Current Assets | 45 | 226 | 171 | 16.193 | - | - | - | - | - | - |
| Inventories | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Receivables | 0 | 45 | 152 | 10.236 | - | - | - | - | - | - |
| Cash | 45 | 181 | 19 | 5.957 | - | - | - | - | - | - |
| Shareholders Funds | -2.189 | -10.653 | -19.719 | -43.741 | - | - | - | - | - | - |
| Social Capital | 90 | 89 | 88 | 107 | - | - | - | - | - | - |
| Debts | 2.234 | 10.879 | 19.891 | 61.377 | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Clc Pharmaceuticals S.r.l.